ANDREW LEE to Cost-Benefit Analysis
This is a "connection" page, showing publications ANDREW LEE has written about Cost-Benefit Analysis.
Connection Strength
0.240
-
The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. J Neuroophthalmol. 2021 Sep 01; 41(3):342-350.
Score: 0.147
-
Evaluation and neuroimaging of the Horner syndrome. Can J Ophthalmol. 2015 Apr; 50(2):107-11.
Score: 0.094